Phillips Lytle
New Drug Application is a Major Milestone for Psychedelic-Assisted Therapy
On December 12, 2023, the Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (MAPS PBC) announced their submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for…